UK - English
Select a Country

Modern Slavery Act Statement

AbbVie Ltd

Modern Slavery Act Transparency Statement

for the year ended 31 December 2016

 

AbbVie believes in every human being’s right to dignity, and respects individual rights as set out in the Universal Declaration of Human Rights. These principles are reflected in our company’s mission and core values. While governments have a key role to respect, protect, promote and fulfil the human rights of their citizens, we recognise that companies have a shared responsibility in promoting human rights within their spheres of influence and applaud the passage of the UK Modern Slavery Act 2015.

Our Organisation

AbbVie Ltd is a subsidiary of AbbVie Inc., a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs approximately 29,000 people worldwide and markets medicines in more than 170 countries. For further information on AbbVie Ltd, please visit www.abbvie.co.uk.

Commitment and Policies

AbbVie contributes to the fulfilment of human rights through compliance with laws and regulations wherever we have operations, as well as through our policies and programs. We are committed to ensuring that slavery and human trafficking do not enter our product supply chains or any part of our business.  We have corporate policies addressing the need for a safe and fair working environment where the rights of those who work for and with us are respected. In addition, we are a member of the international Pharmaceutical Supply Chain Initiative (PSCI) which works to promote responsible practices in labour, health, safety and environmental sustainability in supply chains.

AbbVie’s Code of Business Conduct applies to all AbbVie employees and sets forth our commitment to conduct business with the highest ethical standards and to comply with all applicable laws and regulations. It states that AbbVie is committed to maintaining a work environment free from intimidation, violence or threats of violence.  Our employees worldwide certify their adherence to AbbVie’s Code of Business Conduct annually. Further, our employees and contractors are required to promptly report any known or suspected breach of AbbVie’s Code of Business Conduct or other illegal or unethical behaviour.  Therefore, if there are any concerns relating to a breach of AbbVie’s Code of Business Conduct, these can be raised in confidence and without fear of retaliation.

Expectations of Suppliers

AbbVie’s Supplier Code of Conduct sets out the standards that we require our suppliers to understand and comply with in the areas of ethics, compliance, fair practices, integrity, safety and quality. Specifically, it states our expectation that suppliers:

  • Commit to fair treatment of their employees.
  • Shall not use forced, bonded or indentured labour, involuntary labour or human trafficking.
  • Shall not use child labour.
  • Shall maintain employee files with adequate data to verify ages of employees.
  • Shall pay workers according to applicable wage laws, including minimum wage, overtime hours and mandated benefits as per custom of the country of employment.
     

Our key supplier network is required to certify compliance with AbbVie’s Supplier Code of Conduct and the above requirements. Additionally, in contractual agreements, we oblige our suppliers to comply with all applicable laws and regulations.

Due Diligence

Annually we conduct internal surveys to monitor the awareness of human rights issues in our workplaces. For the year ending 31 December 2016 there were no human rights issues reported. AbbVie Ltd also verifies and ensures all U.K.-based employees and contractors have the right to work in the U.K.

We engage in the verification of our product supply chains which includes evaluating the risk of human trafficking and slavery. As part of our Global Supplier Sustainability programme, AbbVie surveys and measures our most critical suppliers on their environmental and social practices. Specifically, suppliers attest to human slavery and trafficking criteria including whether they have a written policy against human trafficking and slavery, minimum hiring age and wages in accordance with local/national laws. The survey also assesses whether these suppliers have any human trafficking violations. This may be verified via an additional audit by PSCI.   AbbVie uses this information to evaluate, measure and report progress in enhancing our sustainable global supply chain.

Accountability

Any employee or contractor discovered to to be involved in inappropriate conduct or in violation of our Code of Business Conduct, our policies, our procedures and/or applicable laws or regulations, is subject to corrective action, up to and including termination of employment.  Additionally, if AbbVie becomes aware of any actions or conditions not in compliance with our Supplier Code of Conduct, we may seek corrective action.

Matt Regan
Director and General Manager of AbbVie Ltd

Leave the UK site

The Abbvie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Abbvie Internet site that you have requested may be in a language that differs from your country of origin.

The Abbvie Internet site that you have requested may not be optimised for your screen size.

Do you wish to continue to this Abbvie site?

Exit abbvie.co.uk

The product-specific Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The product-specific Internet site that you have requested may not be optimized for your screen size.

Do you wish to continue to this product-specific site?

AXCOR121934c(2) - DECEMBER 2014

Exit abbvie.co.uk

Notice

The “Yes” link below will take you out of AbbVie family of websites

Links which take you out of AbbVie worldwide web sites are not under the control of AbbVie, and AbbVie are not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?